Search Funding Opportunities

Geneva provides comprehensive and tailored proposal development support to researchers engaged in federal grants and contracts. Our expertise within the federal research community ensures a competitive proposal submission.

The following list represents a selection of funding opportunities relevant to the DoD and military medical research community.

Sign up at the bottom of this page to receive a funding bulletin directly to your inbox. Or contact us directly if you need help identifying a funding opportunity.

Contact Us
Search
Title Opportunity Number Funding Agency Deadline
Military Health System Research Program (MHSRP) HT9425-25-MHSRP USAMRAA LOI Submission: 05/28/2024; Application: 06 Sep 24
Prostate Cancer Research Program (PCRP) HT942524PCRP DOD-AMRAA Varies with award
Peer Reviewed Orthopaedic Research Program (PRORP) HT942524PRORP DOD-AMRAA Varies with award
Melanoma Research Program (MRP) HT942524MRP DOD-AMRAA Pre-Application (LOI): 07/29/2024; Full-Application: 08/26/2024
Duchenne Muscular Dystrophy Research Program (DMDRP) HT942524DMDRP DOD-AMRAA Pre-Application (LOI): 08/01/2024; Full-Application: 08/22/2024
Broad Agency Announcement (BAA): Biological Technologies HR001123S0045 DARPA 6/20/2024
DARPA – Biological Technologies Office (BTO) – Somonus DARPARA2402 DARPA 6/17/2024
Broad Agency Announcement(BAA): GOLDen hour extended EVACuation (GOLDEVAC) HR001124S0024 DARPA 6/4/2024
Peer Reviewed Cancer Research Program (PRCRP) HT942524PRCRP DOD-AMRAA Varies with award
AMSSM CRN Request For Proposals RFP AMSSM LOI: 07/12/2024, Full Application: 10/11/2024
ARPA-H Health Science Futures Office Innovative Solutions Opening (ISO) ARPA-H-SOL-24-104 ARPA-H 3/15/2025
ARPA-H Resilient Systems Office Office-wide Innovative Solutions Opening (ISO) ARPA-H-SOL-24-103 ARPA-H 3/15/2025
Prostate Cancer Research Program (PCRP) HT942524PCRP DOD-AMRAA Varies with award
Pancreatic Cancer Research Program (PCARP) HT9425-24-PCARP DOD-AMRAA Varies with award
Autism Research Program (ARP) HT942524ARP DOD-AMRAA Varies with award
Parkinson’s Research Program (PRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Lupus Research Program (LRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Tuberous Sclerosis Complex Research Program (TSCRP) HT942524TSCRP DOD-AMRAA Pre-app due Jun 12, 2024; App due Aug 1, 2024
Tick-Borne Disease Research Program (TBDRP) HT942524TBDRP DOD-AMRAA Pre-app due Jun 26, 2024; App due Oct 3, 2024
Multiple Sclerosis Research Program (MSRP) HT942524MSRP DOD-AMRAA Varies with award
Military Burn Research Program (MBRP) HT942524MBRP DOD-AMRAA Pre-app due Jun 3, 2024; App due Sep 9, 2024
Rare Cancers Research Program (RCRP) HT942524RCRP DOD-AMRAA Varies with award
Alcohol and Substance Use Disorders Research Program (ASUDRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Ovarian Cancer Research Program (OCRP) HT942524OCRP DOD-AMRAA Varies with award
Joint Warfighter Medical Research Program (JWMRP) HT942524SJWMRPMMRDA DOD-AMRAA Pre-app due June3, 2024; App due Aug 29, 2024
Toxic Exposures Research Program (TERP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Kidney Cancer Research Program (KCRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Bone Marrow Failure Research Program (BMFRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Reconstructive Transplant Research Program (RTRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Neurofibromatosis Research Program (NFRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Traumatic Brain Injury and Psychological Health Research Program (TBIPHRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Spinal Cord Injury Research Program (SCIRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Hearing Restoration Research Program (HRRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Lung Cancer Research Program (LCRP) CDMRP Pre-Announcement CDMRP Pre-Announcement Forecasted
Vision Research Program (VRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Amyotrophic Lateral Sclerosis Research Program (ALSRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Peer Reviewed Alzheimer's Research Program (PRARP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
U.S. Army Research Institute for the Behavioral and Social Sciences BAA for Basic Research (FY2025) W911NF24S0005 DOD-AMC 7/1/2024
Breast Cancer Research Program (BCRP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
Epilepsy Research Program (ERP) CDMRP Pre-Announcement DOD-AMRAA Forecasted
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) RFA-NS-24-019 NIH 1/8/2027
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR-24-036 NIH 11/3/2026
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR-24-035 NIH 11/3/2026
Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease NOT-DE-23-007 NIH 5/10/2027
Notice of Special Interest (NOSI): Using Targeted Degradation of Protein and non-Protein Targets for the Development of Novel Anti-Infectives NOT-AI-23-076 NIH 7/17/2026
Broad Agency Announcement (BAA) for the Protection of Deployed Military Personnel From Threats Posed by Arthropod Disease Vectors AFPMB-BAA-24-01 DoD 10/19/2028
2024 Human Exploration Research Opportunities (HERO) Overview 80JSC024NA001 NASA Johnson Space Center 10/30/2024
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 HHS/BARDA-ASPR 10/10/2028
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) RFA-EY-23-001 NIH 6/16/2026
US Special Operations Command - Broad Agency Announcement for Extramural Biomedical Research and Development HT9425-23-S-SOC1 DOD-AMRAA 7/31/2028
United States Army Research Institute for the Behavioral And Social Sciences (ARI) BAA for Basic, Applied, And Advanced Scientific Research W911NF-23-S-0010 DOD-AMC 4/30/2028
Orthopaedic Research and Education Foundation (OREF) various OREF varies with award
AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research NOT-HS-23-003 AHRQ See Notice
Notice of Special Interest (NOSI): Advancing Research for Tickborne Diseases (TBDs) NOT-AI-23-013 NIH Expires January 08, 2026
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) PA-21-265 NIH expires May 27, 2025
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) PA-22-047 NIH expires October 31, 2026
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) PA-22-048 NIH expires October 31, 2026
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) PA-21-164 NIH expires July 18, 2024
Notice of Special Interest (NOSI): Complement in Fundamental Immunology NOT-AI-23-012 NIH expires January 08, 2026
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 NIH expires September 08, 2025
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) PAR-23-047 NIH 1/8/2026
Notice of Special Interest (NOSI): Halting Tuberculosis (TB) Transmission NOT-AI-22-064 NIH 1/8/2026
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) PAR-22-242 NIH 9/8/2025
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) PAR-22-243 NIH 9/8/2025
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early Stage Development (UG3/UH3 Clinical Trial Not Allowed) PAR-22-209 NIH (NINDS, NEI, NIDA, NIEHS) 10/18/2024
DoD USAMRDC FY23-FY27 Broad Agency Announcement for Extramural Medical Research HT9425-23-S-BAA1 DOD-AMRAA 9/30/2027
Broad Agency Announcement Research and Development In Support of The Joint Program Executive Office For Chemical, Biological, Radiological And Nuclear Defense (JPEO-CBRND), JPM MEDICAL AND JPL EB W911SR-22-R-CBRN DOD 6/26/2027
CCRP Initiative: Countermeasures Against Chemical Threats (CounterACT) Therapeutics Discovery and Early-Stage Development (UG3/UH3 Clinical Trial Not Allowed) PAR-22-209 NIH 10/18/2024
Airman Readiness Medical Research (ARMR) Hybrid BAA FA8650-20-S-6008 DoD-AFRL 5/1/2025
Research Interests of the Air Force Office of Scientific Research FA9550-21-S-0001 DOD-AFOSR
US Army Combat Capabilities Development Command Broad Agency Announcement W911QY-20-R-0022 DOD-AMC-ACCAPGN 2/28/2025
BARDA DRIVe EZ-BAA BAA-20-100-SOL-0002 HHS - BARDA 7/6/2024
Notice of Special Interest (NOSI): Advancing Research Needed to Develop a Universal Influenza Vaccine NOT-AI-22-013 NIH (NIAID) 1/8/2025
Notice of Special Interest (NOSI): Accelerating Malaria Vaccine Discovery NOT-AI-22-014 NIH (NIAID) 1/8/2025
Focused Technology Research and Development (R01 Clinical Trial Not Allowed) PAR-22-127 NIH (NIGMS, NIA, NCI) 5/8/2025
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) PAR-22-126 NIH (NIGMS, NIA, NCI) 5/8/2025
Research Program Award (R35 Clinical Trial Optional) RFA-NS-22-038 NIH (NINDS) 7/16/2024
Prospective Observational Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) PAR-22-076 NIH (NINDS) 5/8/2025
Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) NOT-HL-20-814 NIH (NHLBI) 12/21/2024
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) RFA-HL-23-010 NIH (NHLBI) 12/21/2024
Catalyze: Product Definition – Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed) RFA-HL-23-013 NIH (NHLBI) 12/21/2024
Catalyze: Product Definition – Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed) RFA-HL-23-014 NIH (NHLBI) 12/22/2024
RFI: Neurotrauma Diagnosis, Monitoring, and Assessment State of Technology Meeting MTEC-23-11-Neurotrauma MTEC 9/14/2023

Get Funding Alerts Directly to Your Inbox